Surgical Science Sweden AB (OSTO:SUS) Accounts Payable: kr0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:SUS Surgical Science Sweden AB OSTO:SUS
83 GF Score
Price kr51.10
GF Value kr155.97
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Surgical Science Sweden AB Accounts Payable?

Surgical Science Sweden AB OSTO:SUS -1.35% 83 Accounts Payable is kr0 Mil as of Jun. 2026. GuruFocus rates OSTO:SUS with a GF Score™ of 83/100 and a GF Value™ of kr155.97 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Surgical Science Sweden AB's Accounts Payable for the quarter that ended in Jun. 2026 was kr0 Mil.

Surgical Science Sweden AB's quarterly Accounts Payable declined from Dec. 2025 (kr36 Mil) to Mar. 2026 (kr0 Mil) but then stayed the same from Mar. 2026 (kr0 Mil) to Jun. 2026 (kr0 Mil).

Surgical Science Sweden AB's annual Accounts Payable increased from Dec. 2023 (kr41 Mil) to Dec. 2024 (kr58 Mil) but then declined from Dec. 2024 (kr58 Mil) to Dec. 2025 (kr36 Mil).

Surgical Science Sweden AB Accounts Payable Related Terms

Surgical Science Sweden AB Accounts Payable Historical Data

* Premium members only.

The historical data trend for Surgical Science Sweden AB's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surgical Science Sweden AB Accounts Payable Chart

Surgical Science Sweden AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.37 65.69 41.29 58.45 36.25

Surgical Science Sweden AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 36.25 0.00 0.00
OSTO:SUS
83GF Score
Surgical Science Sweden AB OSTO:SUS
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Surgical Science Sweden AB Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of kr0 Mil mean?
Surgical Science Sweden AB (OSTO:SUS) has a Accounts Payable of kr0 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Surgical Science Sweden AB and its competitors.
Is Surgical Science Sweden AB's Accounts Payable too high?
Surgical Science Sweden AB's current Accounts Payable is kr0 Mil. Overall, Surgical Science Sweden AB has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Surgical Science Sweden AB's Accounts Payable compare to VEEV and BTSG?
Surgical Science Sweden AB's Accounts Payable of kr0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Healthcare Providers & Services company?
A good Accounts Payable depends on the Healthcare Providers & Services industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Surgical Science Sweden AB and its competitors. Surgical Science Sweden AB's current Accounts Payable is kr0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Science Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Surgical Science Sweden AB (OSTO:SUS) is currently considered Significantly Undervalued. The stock's GF Value™ is kr155.97, compared to a current price of kr51.10 — trading 67.2% below its estimated fair value. The current Accounts Payable is kr0 Mil. Surgical Science Sweden AB's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Surgical Science Sweden AB (OSTO:SUS), the current Accounts Payable is kr0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Surgical Science Sweden AB (OSTO:SUS) Overvalued in 2026?

Based on GuruFocus' analysis, Surgical Science Sweden AB stock appears to be undervalued. The current stock price of kr51.10 is trading 67.2% below its estimated GF Value™ of kr155.97. GuruFocus considers Surgical Science Sweden AB to be Significantly Undervalued.

Key valuation signals for OSTO:SUS:

  • Accounts Payable: kr0 Mil
  • GF Value™: kr155.97 vs. price of kr51.10 (67.2% below fair value)
  • GF Score™: 83/100 with 4 warning signs

No single metric tells the full story. See the OSTO:SUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Surgical Science Sweden AB Business Description

Other Exchanges SUSRF:USA4P41:Germany
Address Drakegatan 7A, Gothenburg, SWE, SE-412 50
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments: Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations prior to entering the clinical environment, as well as support and services. Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments, and also simulators for medical device companies.
83GF Score

Get the complete analysis for OSTO:SUS

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr51.10
Price
kr155.97
GF Value